This report analyses Indian patent and design statistics for May 17th to 24th, 2024, focusing on applications, grants, and city-wise trends. Authored by BananaIP, it offers a neutral and factual overview for legal and IP professionals.
Read more about Indian Patent and Design Statistics 2024 (May 17th to 24th)Category: Patents
Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)
The Madras High Court clarified the interpretation of Section 3c regarding patent eligibility of monoclonal antibodies in India. The Court held that synthetic antibodies may be patentable if they demonstrate novelty or technical advancement.
Read more about Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)Court criticizes Patent Office for using outdated CRI Guidelines
The Madras High Court condemned the Patent Office’s reliance on outdated CRI guidelines in Microsoft’s patent application case, highlighting the significance of technical effect in computer related inventions. The court allowed the appeal and directed a new evaluation.
Read more about Court criticizes Patent Office for using outdated CRI GuidelinesNote on the WIPO Treaty on Intellectual Property, Genetic Resources, and Associated Traditional Knowledge
The WIPO Treaty on Intellectual Property, Genetic Resources, and Associated Traditional Knowledge seeks to enhance transparency and fairness in the patent system. It establishes disclosure requirements and safeguards for genetic resources and traditional knowledge within international intellectual property law.
Read more about Note on the WIPO Treaty on Intellectual Property, Genetic Resources, and Associated Traditional KnowledgeVictory for Novozymes: Madras High Court Overrules Patent Office’s Refusal
The Madras High Court has reversed the Patent Office’s rejection of Novozymes’ patent for enzyme granules in animal feed, emphasizing the need for detailed reasoning in refusal orders. The decision clarifies the application of inventive step and Section 3d in Indian patent law.
Read more about Victory for Novozymes: Madras High Court Overrules Patent Office’s RefusalCancerous Battle: Novartis and NATCO clash over Eltrombopag
The Delhi High Court Division Bench set aside an injunction against Natco Pharma in the Novartis Eltrombopag patent dispute. The judgment provides key guidance on patent validity challenges and the requirements under Section 3(d) of the Patents Act in pharmaceutical cases.
Read more about Cancerous Battle: Novartis and NATCO clash over EltrombopagSufficiency of Disclosure – Ericsson vs Lava – Part X
The Delhi High Court’s decision in Ericsson vs Lava addresses sufficiency of disclosure under the Patents Act. The Court found Ericsson’s patents to be sufficiently disclosed, rejecting Lava’s revocation claims.
Read more about Sufficiency of Disclosure – Ericsson vs Lava – Part XTransparency Triumphs : Patent Refusals must elucidate clear grounds
The Delhi High Court has reiterated the need for transparency in patent refusal orders, stating that clear grounds must be provided. The judgment highlights the importance of detailed reasoning and independent assessment of each claim in patent applications.
Read more about Transparency Triumphs : Patent Refusals must elucidate clear groundsIndian Patent and Design Statistics 2024 (May 3rd to 10th)
This report analyses Indian patent and design statistics for the week of May 3rd to 10th, 2024, offering a comprehensive overview of trends and city-wise distributions. Key figures and comparative insights provide clarity on the evolving IP landscape in India.
Read more about Indian Patent and Design Statistics 2024 (May 3rd to 10th)Novelty and Inventive Step analysis (Part B) – Ericsson Vs. Lava – Part IX
The Delhi High Court’s analysis in Ericsson vs. Lava addresses the novelty and inventive step of key standard essential patents for 3G and EDGE technology. This post summarises the court’s findings on the technical advancements and legal standards applied in evaluating Ericsson’s patents, maintaining a clear and factual legal perspective.
Read more about Novelty and Inventive Step analysis (Part B) – Ericsson Vs. Lava – Part IX